Pressroom: Media Coverage

Showing 281 - 300 of 656 news items


Pared Back Prostate Cancer Screening May Save Lives

A study led by epidemiologist Andrew Vickers found that certain men may need only three PSA tests in their lifetime.

April 17, 2013
New Treatment Pokes Holes in Tumors, Literally

Interventional radiologist Constantinos Sofocleous discussed a study he led that found that irreversible electroporation, a technique that sends electrical pulses via tiny needles directly to tumors, successfully destroys cancer cells without harming nearby healthy cells.

April 15, 2013
Unorthodox Tests on Rodents Help Ridgewood 9-Year-Old Beat Cancer

Pediatric oncologist Leonard Wexler spoke about using personalized mice models implanted with a patient’s unique tumor to test new drug combinations.

April 14, 2013
Uterine Cancer Tied to Later Colon Cancer

Gynecologist and geneticist Noah Kauff commented on a study that found that women diagnosed with uterine cancer may have a higher risk of developing colon cancer later in life. He said the increased risk could be due to women with a hereditary condition known as Lynch syndrome.

April 11, 2013
Writing Program for Cancer Patients

Visible Ink founder Judith Kelman discussed the Memorial Sloan Kettering program she runs that connects patients with experienced writers, editors, and teachers to help them tell their stories in writing. A Memorial Sloan Kettering patient and program participant was also interviewed.

April 10, 2013
Taking a Supplement? Tell Your Doctor

Integrative Medicine Service Chief Barrie Cassileth commented on the importance of informing your doctor of all medicines you take, including supplements.

April 8, 2013
MEK: A Single Drug Target Shows Promise in Multiple Cancers

Endocrinologist James Fagin spoke about a study he led that found that an investigational drug may help some patients with thyroid cancer who are unable to absorb radioactive iodine, the most effective therapy for the disease.

April 5, 2013
Antidepressant Lessens Chemo-Related Pain

Physiatrist Michael Stubblefield commented on a study that found that an antidepressant can help relieve chronic pain caused by certain cancer drugs.

April 2, 2013
World-Class Cancer Treatment, Closer to Home

Victor Ribaudo, Executive Director of Memorial Sloan Kettering’s Regional Care Network, spoke about plans to open a new suburban outpatient treatment center in Middletown, New Jersey.

April 2, 2013
The New Breast Rating You Need to Know

Surgical oncologist Monica Morrow explained how breast density affects cancer risk.

April 1, 2013
Robin Roberts: "I'm Stronger Than I Thought I Was"

Hematologist-oncologist Sergio Giralt was interviewed about treating Good Morning America co-host Robin Roberts, who received a stem cell transplant at Memorial Sloan Kettering.

March 31, 2013
When a Famous Hospital Didn't Want an Expensive New Drug

Medical oncologist Leonard Saltz and epidemiologist Peter Bach commented on Memorial Sloan Kettering’s decision not to carry a new colorectal cancer drug due to its cost.

March 28, 2013
Skin Care for Cancer Patients

Dermatologist Mario Lacouture was interviewed about the effects of chemotherapy on the skin.

March 25, 2013
Surgery Restoring Penis after Prostate Cancer Increasing

Director of Memorial Sloan Kettering’s Male Sexual and Reproductive Medicine Program John Mulhall discussed ways to improve sexual function after prostate cancer surgery.

March 25, 2013
Little Support for Idea of Medicare Payments That Vary

Epidemiologist Peter Bach commented on a report he coauthored that argues that Medicare payments should not be adjusted on a regional basis.

March 23, 2013
Can Research "Dream Teams" Find the Cure for Cancer?

Medical oncologist Larry Norton discussed cancer advances made possible by collaborative efforts like those described in a recent TIME magazine article.

March 21, 2013
Experimental Cancer Treatment Offers Hope

Medical oncologist Renier Brentjens was interviewed about a study he co-led with cell researcher Michel Sadelain that found that genetically modified immune cells were able to induce complete remissions in patients with advanced B cell acute lymphoblastic leukemia.

March 21, 2013
Cell Therapy Shows Promise for Acute Type of Leukemia

Medical oncologist Renier Brentjens and cell researcher Michel Sadelain reported for the first time that genetically modified immune cells were able to induce complete remissions in all five patients treated with the experimental therapy. Patients had advanced B cell acute lymphoblastic leukemia, a disease with limited treatment options.

March 21, 2013
New Medical Technology Draws on Nature for Inspiration

Medical oncologist Howard Scher commented on an investigational microchip that can count and sort cancer cells so doctors can determine how well treatments are working.

March 19, 2013